• Jazz Pharmaceuticals plc, of Dublin, Ireland, reported third-quarter revenue of $176 million, with net income coming in at $33.6 million, or 56 cents per share. Based on analyst estimates, revenue soundly beat expectations, while earnings-per-share numbers came up short.